Usefulness of the Urine Methylation Test (Bladder EpiCheck<sup>®</sup>) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells—An Institutional Study
Urothelial bladder cancer is a heterogeneous disease and one of the most common cancers worldwide. Bladder cancer ranges from low-grade tumors that recur and require long-term invasive surveillance to high-grade tumors with high mortality. After the initial contemporary treatment in non-muscle invas...
Main Authors: | Karla B. Peña, Francesc Riu, Anna Hernandez, Carmen Guilarte, Joan Badia, David Parada |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/13/3855 |
Similar Items
-
Bladder EpiCheck in high risk population
by: P.F. Bassi, et al.
Published: (2020-01-01) -
The diagnostic accuracy of Bladder EpiCheck in high-risk population
by: M. Racioppi, et al.
Published: (2020-07-01) -
En Bloc Resection of Bladder Tumor—Is It the Way Forward?
by: Christian Daniel Fankhauser, et al.
Published: (2021-05-01) -
The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence
by: Mariangela Mancini, et al.
Published: (2020-09-01) -
The role of bladder EpiCheck test in follow-up of patients with NMBC recently treated with endovesical therapy
by: M. Ragonese, et al.
Published: (2020-10-01)